• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

Argentina announces COVID-19 vaccine supply deal with Moderna

firstwordpharmaJuly 09, 2021

Tag: Moderna , COVID-19 , Vaccine

Argentina says it will sign a COVID-19 vaccine supply agreement with Moderna, as the country attempts to ramp up the inoculation of its population and avoid a possible third wave of coronavirus infections, reported the Financial Post.

Argentina announces COVID-19 vaccine supply deal with Moderna

Cabinet chief Santiago Cafiero said a deal would be signed with Moderna on Monday, but did not detail the number of doses being bought or the agreed delivery dates.

Argentina has so far largely built its COVID-19 inoculation program around Russia's Sputnik V vaccine, China's Sinopharm vaccine and AstraZeneca's vaccine.


Previous:Venezuela payment to COVAX received after funds blocked - Gavi

Next:Xilis Raises $70 Million Series A Financing to Advance Diagnostic and Drug Discovery and Development Platform Leveraging Proprietary MicroOrganoSphere Technology

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Argentina announces COVID-19 vaccine supply deal with Moderna | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Recommended flu vaccine 2023-2024 by WHO

Recommended flu vaccine 2023-2024 by WHO
Influenza Vaccine in Vial/Syringe

Influenza Vaccine in Vial/Syringe
Hualan H7N9 Inactivated Influenza Vaccine by Hualan Bio

Hualan H7N9 Inactivated Influenza Vaccine by Hualan Bio
Influenza Vaccine(Split Virion),Inactivated with good safety

Influenza Vaccine(Split Virion),Inactivated with good safety
Hualan Influenza Vaccine(Split Virion),Inactivated

Hualan Influenza Vaccine(Split Virion),Inactivated
B28 pp 100ml autoclaved vaccine bottle

B28 pp 100ml autoclaved vaccine bottle
Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains

Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains
Group A and C Meningococcal+Haemophilus Type B Conjugate Vaccine

Group A and C Meningococcal+Haemophilus Type B Conjugate Vaccine
Recombinant Hepatitis B Vaccine(Saccharomyces Cerevisiae)

Recombinant Hepatitis B Vaccine(Saccharomyces Cerevisiae)
2023-2024 flu vaccine

2023-2024 flu vaccine

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service